Abstract
Myasthenia Gravis (MG) is an autoimmune disease resulting from the action of autoantibodies against nicotinic acetylcholine receptors (nAChRs), interfering with the proper communication between the neurotransmitter acetylcholine (ACh) released by the axon and its nAChR receptor, expressed by the muscle fiber. The detection of anti-nAChR autoantibodies has 100% specificity for the diagnosi…